Obesity, food supplementation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria were established for the participation of the research: adult women, aged between 20 and 59 years and BMI between 25 and 40 kg / m2.
Exclusion criteria
Exclusion criteria: Adult women diagnosed with renal, cardiovascular, hepatic, cancer, pregnant or lactating diseases will be excluded from the study, following a specific diet; Chronic alcoholics; On the use of anti-inflammatory medications or medicines that affect appetite or body weight; In inflammatory or infectious process on the day of collection; Who have participated in any food restriction program, in the use of food supplements in the last six months and lactose intolerant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1 Reduction of body adiposity determined by dual energy radiological absortometry based on the observation of a variation of at least 5% in the pre or post intervention measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2 Reduction of the body mass index calculated from the weight and height that were measured by means of the double energy radiological abortometry and of an AVANUTRI stadiometer from the observation of a variation of at least 5% in the pre or post intervention measurements;Expected outcome 3 Reduction of waist circumference. The circumference was to be determined with a tape measure placed without pressing, in horizontal plane at the level of the natural waist. If it was difficult to identify the natural waist, the measurement was performed at the midpoint between the lower portion of the last rib and the iliac crest from the observation of a variation of at least 5% in the pre or post intervention measurements;Expected outcome 4 Reduction of the sagittal abdominal diameter measured using the anthropometric rule of mobile stem wood from the observation of a variation of at least 5% in the pre or post intervention measurements ;Expected outcome 5 Reduction of ultra sensitive protein and fasting glycemia determined by the chemiluminescence method. From the observation of a variation of at least 5% in the pre- or post-intervention measurements;Expected outcome 6 Reduction of fasting insulin dosed by the method of immunoturbidimetry in architect 8000. From the observation of a variation of at least 5% in the pre or post intervention measurements;Expected outcome 7 Increased concentrations of leptin, nesfatin and adiponectin performed by the Elisa method. From the observation of a variation of at least 5% in the pre or post intervention measurements | — |
Countries
Brazil
Contacts
Faculdade de Nutrição da Universidade Federal de Goiás